PROSTest

There is 1 paper on PROSTest in aging research: 1 observational study in people.

Biomarker

1 paper studies it1 finding

See all 1 papers on PROSTest

“PROSTest demonstrated an overall accuracy of 91% (95% CI: 84.1-95.6%) with an NPV of 89%.”
Clinical Utility of PROSTest: A Prospective Study Suggesting Reduction in Unnecessary MRI and Biopsy in Men Evaluated for Prostate CancerCancers2026doi:10.3390/cancers18050871
  • Humans1

Associations

1

Prostate cancer

upin humans1

1 study
  1. PROSTest predicts prostate cancer in humans (men evaluated for prostate cancer) (overall accuracy 91% (95% CI: 84.1-95.6%), NPV 89% (51.6-98.4%)).

    “PROSTest demonstrated an overall accuracy of 91% (95% CI: 84.1-95.6%) with an NPV of 89%.”

    Human trialmen evaluated for prostate cancerwhole bloodmalesn = 111

    Clinical Utility of PROSTest: A Prospective Study Suggesting Reduction in Unnecessary MRI and Biopsy in Men Evaluated for Prostate Cancer

    Cancers

More on Prostate cancer

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 1Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months